- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.10. | FibroBiologics, Charles River Partner to Manufacture Cell-Based Therapies | ||
| 18.10. | Chiesi Introduces New Innovation Platform | ||
| 17.10. | eXmoor, Virica Partner to Enhance AAV Production | ||
| 17.10. | Sanofi & Orano Med Join Forces to Advance Targeted Alpha Therapies in Oncology | ||
| 17.10. | Inizio Medical Appoints Matt Wadyka as President, US Medical Affairs | ||
| 17.10. | Poseida Nominates New Development Candidate Under Its Collaboration with Roche | ||
| 17.10. | Viatris Enters Exclusive Licensing Agreement with Lexicon | ||
| 16.10. | PDC Acquires Resenex to Expand Fluid Management Solutions | ||
| 16.10. | UF Health Researchers Awarded $11.8M Grant to Fight Antibiotic-Resistance | ||
| 16.10. | Univercells Technologies by Donaldson Launches scale-X nexo bioreactor | ||
| 16.10. | EUROAPI Names Olivier Falut as Chief Financial Officer | ||
| 16.10. | Fresenius Kabi and Cellular Origins Collaborate on CGT Automation | ||
| 16.10. | AtomVie, Radiopharm Ventures Partner to Develop & Manufacture Monoclonal Antibody | ||
| 16.10. | Matica Bio, Mongoose Bio Partner to Accelerate TCR-T Cell Therapy Development | ||
| 15.10. | SIRIO Opens €16M Packaging Facility on German Site | ||
| 15.10. | Lonza Completes Drug Product Services Facility Expansion in Basel | ||
| 15.10. | Lundbeck Agrees to Acquire Longboard Pharmaceuticals | ||
| 15.10. | Neurophet, AriBio Partner to Develop a Next-Gen Platform for Alzheimer's Diagnosis | ||
| 15.10. | VGXI Taps Cryoport for Biostorage and Bioservices | ||
| 15.10. | LGM Pharma Expands Its Analytical Testing Services | ||
| 14.10. | Aptar CSP's N-Sorb Accepted to FDA's Emerging Tech Program | ||
| 14.10. | Pfizer's HYMPAVZI Approved to treat Hemophilia A or B Without Inhibitors | ||
| 14.10. | Chiesi Group Opens Biotech Center of Excellence in Parma, Italy | ||
| 14.10. | RedHill Biopharma Secures BARDA Funding to Advance Ebola Treatment | ||
| 14.10. | Samsung Biologics Launches High-Concentration Formulation Platform |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
